Phibro Animal Health (NASDAQ:PAHC) CEO Jack Bendheim Sells 3,520 Shares of Stock

December 5, 2025 by InsiderTrades.com

Key Points

CEO Jack Bendheim sold 3,520 shares on Dec. 3 at an average price of $40.77, reducing his stake to 53,280 shares (a 6.2% decrease) after a series of large insider sales in October–November including blocks of 38,303 and 21,536 shares.
Phibro beat expectations for the quarter with $0.73 EPS and $363.89M revenue, set FY2026 guidance of 2.64–2.81 EPS, and currently carries a consensus analyst rating of "Hold" with a $31.40 price target.
The stock traded down about 1.7% to $40.07 (market cap ≈ $1.62B) and the company announced a quarterly dividend of $0.12 (annualized $0.48, ~1.2% yield).

Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report) CEO Jack Bendheim sold 3,520 shares of the business's stock in a transaction dated Wednesday, December 3rd. The stock was sold at an average price of $40.77, for a total value of $143,510.40. Following the sale, the chief executive officer owned 53,280 shares of the company's stock, valued at $2,172,225.60. The trade was a 6.20% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Jack Bendheim also recently made the following trade(s):

On Tuesday, November 25th, Jack Bendheim sold 7,040 shares of Phibro Animal Health stock. The shares were sold at an average price of $43.93, for a total transaction of $309,267.20.
On Wednesday, November 26th, Jack Bendheim sold 5,280 shares of Phibro Animal Health stock. The stock was sold at an average price of $44.02, for a total transaction of $232,425.60.
On Monday, November 17th, Jack Bendheim sold 5,280 shares of Phibro Animal Health stock. The stock was sold at an average price of $44.56, for a total transaction of $235,276.80.
On Thursday, November 13th, Jack Bendheim sold 8,801 shares of Phibro Animal Health stock. The shares were sold at an average price of $44.47, for a total transaction of $391,380.47.
On Wednesday, November 12th, Jack Bendheim sold 21,536 shares of Phibro Animal Health stock. The shares were sold at an average price of $45.23, for a total transaction of $974,073.28.
On Monday, November 10th, Jack Bendheim sold 38,303 shares of Phibro Animal Health stock. The stock was sold at an average price of $45.29, for a total transaction of $1,734,742.87.
On Friday, November 7th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $42.86, for a total value of $150,867.20.
On Tuesday, November 4th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $43.10, for a total value of $151,712.00.
On Thursday, October 30th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $41.07, for a total value of $144,566.40.
On Tuesday, October 28th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $41.56, for a total value of $146,291.20.

Phibro Animal Health Stock Down 1.7%

Phibro Animal Health stock traded down $0.70 during midday trading on Friday, hitting $40.07. 5,466 shares of the company were exchanged, compared to its average volume of 279,025. The company has a debt-to-equity ratio of 2.32, a current ratio of 3.09 and a quick ratio of 1.35. Phibro Animal Health Corporation has a fifty-two week low of $16.16 and a fifty-two week high of $46.42. The company's fifty day moving average price is $41.20 and its 200-day moving average price is $33.84. The company has a market cap of $1.62 billion, a PE ratio of 24.11, a price-to-earnings-growth ratio of 1.17 and a beta of 0.77.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings data on Wednesday, November 5th. The company reported $0.73 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.58 by $0.15. The company had revenue of $363.89 million for the quarter, compared to analyst estimates of $345.44 million. Phibro Animal Health had a net margin of 4.85% and a return on equity of 36.26%. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. On average, research analysts predict that Phibro Animal Health Corporation will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 17th. Shareholders of record on Wednesday, November 26th will be given a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date of this dividend is Wednesday, November 26th. Phibro Animal Health's dividend payout ratio is presently 28.92%.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the company. JPMorgan Chase & Co. raised their target price on Phibro Animal Health from $45.00 to $50.00 and gave the company an "overweight" rating in a research note on Friday, November 7th. Zacks Research lowered Phibro Animal Health from a "strong-buy" rating to a "hold" rating in a research note on Monday, November 10th. Morgan Stanley set a $34.00 price objective on Phibro Animal Health in a report on Thursday, August 28th. Weiss Ratings reiterated a "buy (b-)" rating on shares of Phibro Animal Health in a research note on Monday. Finally, Bank of America raised their price target on shares of Phibro Animal Health from $19.00 to $27.00 and gave the stock an "underperform" rating in a research report on Friday, August 29th. Two investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $31.40.

Get Our Latest Analysis on PAHC

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. National Bank of Canada FI bought a new stake in shares of Phibro Animal Health during the 1st quarter valued at about $30,000. Financial Management Professionals Inc. acquired a new position in Phibro Animal Health in the second quarter valued at approximately $32,000. Hughes Financial Services LLC acquired a new position in Phibro Animal Health in the third quarter valued at approximately $40,000. iSAM Funds UK Ltd bought a new position in shares of Phibro Animal Health during the third quarter valued at approximately $61,000. Finally, EverSource Wealth Advisors LLC raised its position in shares of Phibro Animal Health by 7,671.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,720 shares of the company's stock worth $69,000 after purchasing an additional 2,685 shares during the period. 99.34% of the stock is owned by institutional investors and hedge funds.

About Phibro Animal Health

(Get Free Report)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.